Opportunities

If you are interested in a career at Morphic please submit your CV below.

About Morphic Therapeutic

Morphic Therapeutic is a biotechnology company developing a new generation of oral integrin therapies.  Drawing on integrin biology breakthroughs from the lab of noted entrepreneur and scientific founder Tim Springer, Morphic has developed an exclusive platform to build on these discoveries, complemented by a partnership with computational chemistry leader Schrödinger, Inc., that facilitates the rapid and iterative design of clinical candidates.  Morphic was created in 2015 with support from Timothy Springer, PhD, Polaris Partners, Schrödinger Inc., and ShangPharma and raised $51.5M in 2016 from top tier investors.  In September 2018, Morphic Therapeutic completed an $80 million Series B financing round to advance multiple programs into the clinic.  Last October, we announced a collaboration with AbbVie on a subset of our fibrosis programs. Under the terms of the agreement, AbbVie paid Morphic an upfront payment of $100 million for exclusive license options on product candidates directed at multiple targets. Morphic retains co-development rights in liver indications. Integrins are involved in multiple disease areas, including inflammation, fibrosis, vascular diseases and cancer, and inhibitors are clinically validated.  The combination of Morphic’s deep integrin expertise with your skills will enable a rapid path to novel and effective drugs for both orphan and blockbuster indications.  In addition, we recently announced that it has entered into a research and development collaboration with Janssen Biotech, Inc. (Janssen) to discover and develop novel integrin therapeutics for patients with conditions not adequately addressed by current therapies. Johnson & Johnson Innovation LLC facilitated the transaction. The collaboration focuses on several undisclosed integrin targets and will explore both inhibitors and activators of integrin function.  Under the terms of the agreement, the companies will collaborate through preclinical development to identify and advance candidates. Morphic is located in the AstraZeneca BioHub in Waltham, MA. We seek a highly talented and motivated individual to join our culture of teamwork, craftsmanship, tenacity, compassion, and integrity.

Job description

Morphic Therapeutic is seeking a skilled medicinal chemist to join our team. The role will suit an individual with a passion for science, strong problem-solving skills, and a sense of urgency to deliver in an early stage, fast paced biotech company.

Responsibilities

  • Provide chemistry leadership for project teams
  • Utilize modern drug design techniques to design inhibitors based on structural insights, in silico modeling and physiochemical properties
  • Work closely with Schrödinger scientists to utilize structure-based drug design and computational predictions to advance projects quickly and efficiently
  • Communicate and enable external chemistry teams to solve synthetic issues in an efficient manner
  • Work closely with internal chemists to advance projects quickly in a collaborative manner
  • As a key member of Morphic’s medicinal chemistry team, positively influence Morphic’s overall scientific and corporate culture

Qualifications

  • Ph.D. (or equivalent) in chemistry with 5+ years of research experience
  • Deep understanding of synthetic and medicinal chemistry, as evidenced by a record of achievement
  • Track record of innovation and creative problem solving
  • Previous project leadership experience preferred
  • Experience in structure-based drug design and working with computational chemists/ structural biologists preferred
  • Flexible, tenacious, open minded, creative and inclusive
  • Ability to guide external synthetic organic chemistry at CROs
  • Exceptional communication and interpersonal skills, known as an excellent team member working together to solve difficult scientific challenges

 

Morphic Therapeutic is an equal opportunity employer committed to providing an environment that maximizes our employees’ development and achievement goals. We strive to treat each employee as an individual, as we seek to foster a spirit of teamwork to help change patients’ lives. In addition to a competitive compensation and benefits package that includes medical, dental and vision coverage, a 401K and a generous vacation and holiday schedule.

About Morphic Therapeutic

Morphic Therapeutic is a biotechnology company developing a new generation of oral integrin therapies.  Drawing on integrin biology breakthroughs from the lab of noted entrepreneur and scientific founder Tim Springer, Morphic has developed an exclusive platform to build on these discoveries, complemented by a partnership with computational chemistry leader Schrödinger, Inc., that facilitates the rapid and iterative design of clinical candidates.  Morphic was created in 2015 with support from Timothy Springer, PhD, Polaris Partners, Schrödinger Inc., and ShangPharma and raised $51.5M in 2016 from top tier investors.  In September 2018, Morphic Therapeutic completed an $80 million Series B financing round to advance multiple programs into the clinic.  Last October, we announced a collaboration with AbbVie on a subset of our fibrosis programs. Under the terms of the agreement, AbbVie paid Morphic an upfront payment of $100 million for exclusive license options on product candidates directed at multiple targets. Morphic retains co-development rights in liver indications. Integrins are involved in multiple disease areas, including inflammation, fibrosis, vascular diseases and cancer, and inhibitors are clinically validated.  The combination of Morphic’s deep integrin expertise with your skills will enable a rapid path to novel and effective drugs for both orphan and blockbuster indications.  In addition, we recently announced that it has entered into a research and development collaboration with Janssen Biotech, Inc. (Janssen) to discover and develop novel integrin therapeutics for patients with conditions not adequately addressed by current therapies. Johnson & Johnson Innovation LLC facilitated the transaction. The collaboration focuses on several undisclosed integrin targets and will explore both inhibitors and activators of integrin function.  Under the terms of the agreement, the companies will collaborate through preclinical development to identify and advance candidates. Morphic is located in the AstraZeneca BioHub in Waltham, MA. We seek a highly talented and motivated individual to join our culture of teamwork, craftsmanship, tenacity, compassion, and integrity.

Job description

Morphic Therapeutic is seeking an accomplished, innovative, and motivated Protein Scientist/Engineer. The position will be part of world-class research team at Morphic, working together towards transformative therapeutics for autoimmune, fibrotic diseases, and immuno-oncology. The successful candidate will be responsible for creating novel biologics against disease targets using state-of-the-art yeast libraries.

Responsibilities

  • Working with a strategic academic partner to establish a yeast display platform
  • Identifying and engineering reagents for target identification and validation
  • Designing selection strategies and co-developing functional assays
  • Biophysical and biochemical characterizations of antibody-antigen interaction
  • Production of antibody for in vivo and in vitro studies
  • Present results (written and oral) to internal and external audiences
  • Mentoring and developing junior staff

Qualifications

  • Ph.D. in Biochemistry, Molecular Biology, Structural Biology, or Bioengineering with a minimum of two years of post-graduate research experience.
  • 2+ years of hands-on experience in yeast display and/or phage display, and protein engineering is required.
  • In-depth knowledge of display technologies and libraries is required.
  • Experience in mammalian protein expression, purification and characterization is highly desirable.
  • Experience in antibody affinity maturation and other display technologies is a plus.
  • Highly-skilled in recombinant DNA techniques
  • Knowledge in protein crystallography, cryo-EM, and structural biology is highly desirable.
  • Demonstrated abilities of critical and creative thinking
  • Strong problem-solving track record
  • Proven interest in mentoring and guiding junior employees
  • Experience in managing and collaborating with CROs is a plus
  • Strong organization, interpersonal and communication skills are required.

 

Morphic Therapeutic is an equal opportunity employer committed to providing an environment that maximizes our employees’ development and achievement goals. We strive to treat each employee as an individual, as we seek to foster a spirit of teamwork to help change patients’ lives. In addition to a competitive compensation and benefits package that includes medical, dental and vision coverage, a 401K and a generous vacation and holiday schedule.

About Morphic Therapeutic

Morphic Therapeutic is a biotechnology company developing a new generation of oral integrin therapies.  Drawing on integrin biology breakthroughs from the lab of noted entrepreneur and scientific founder Tim Springer, Morphic has developed an exclusive platform to build on these discoveries, complemented by a partnership with computational chemistry leader Schrödinger, Inc., that facilitates the rapid and iterative design of clinical candidates.  Morphic was created in 2015 with support from Timothy Springer, PhD, Polaris Partners, Schrödinger Inc., and ShangPharma and raised $51.5M in 2016 from top tier investors.  In September 2018, Morphic Therapeutic completed an $80 million Series B financing round to advance multiple programs into the clinic.  Last October, we announced a collaboration with AbbVie on a subset of our fibrosis programs. Under the terms of the agreement, AbbVie paid Morphic an upfront payment of $100 million for exclusive license options on product candidates directed at multiple targets. Morphic retains co-development rights in liver indications. Integrins are involved in multiple disease areas, including inflammation, fibrosis, vascular diseases and cancer, and inhibitors are clinically validated.  The combination of Morphic’s deep integrin expertise with your skills will enable a rapid path to novel and effective drugs for both orphan and blockbuster indications.  In addition, we recently announced that it has entered into a research and development collaboration with Janssen Biotech, Inc. (Janssen) to discover and develop novel integrin therapeutics for patients with conditions not adequately addressed by current therapies. Johnson & Johnson Innovation LLC facilitated the transaction. The collaboration focuses on several undisclosed integrin targets and will explore both inhibitors and activators of integrin function.  Under the terms of the agreement, the companies will collaborate through preclinical development to identify and advance candidates. Morphic is located in the AstraZeneca BioHub in Waltham, MA. We seek a highly talented and motivated individual to join our culture of teamwork, craftsmanship, tenacity, compassion, and integrity.

Job description

Morphic Therapeutic is seeking a highly motivated, experienced, and accomplished computational chemist. This person will work closely with Schrodinger scientists in a valued and successful collaboration to advance multiple early – late stage projects. At the same time, the successful candidate will build internal capabilities at Morphic to compliment Schrodinger tools and efforts, as well as interacting with other collaborators. An additional responsibility will be to set the company strategy in chemoinformatics, and address future needs in this area. As an integral member of discovery project teams, the candidate will work collaboratively with multiple scientists in medicinal chemistry, biology and DMPK to advance clinical candidates in areas of high medical need.

Responsibilities

  • Leader of computational chemistry and chemoinformatics at Morphic
  • Build strong relationships with Schrodinger scientists and work in a highly collaborative manner
  • Work closely with internal medicinal chemists, biologists, DMPK and other scientists to set project strategy
  • Determine what additional computational and chemoinformatics tools are needed to compliment current resources
  • Work with pharma collaborators to coordinate diverse project teams
  • Advance projects through use of these tools directly towards clinical candidates to impact patients

Qualifications

  • PhD. in relevant scientific field and 10+ years of industry experience
  • Deep knowledge of multiple computational chemistry and chemoinformatics platforms
  • Regarded as a computational chemistry thought leader
  • Excellent written and oral communication skills
  • General knowledge of medicinal chemistry and DMPK
  • Demonstrated ability to think logically and critically to build computational hypotheses across multiple projects
  • Key contributor to discovery project teams while forming productive working relationships
  • Successful track record of advancing clinical candidates collaboratively in a positive team environment
  • Experience with chemoinformatics, data storage, and analysis

 

Morphic Therapeutic is an equal opportunity employer committed to providing an environment that maximizes our employees’ development and achievement goals. We strive to treat each employee as an individual, as we seek to foster a spirit of teamwork to help change patients’ lives. In addition to a competitive compensation and benefits package that includes medical, dental and vision coverage, a 401K and a generous vacation and holiday schedule.

About Morphic Therapeutic

Morphic Therapeutic is a biotechnology company developing a new generation of oral integrin therapies.  Drawing on integrin biology breakthroughs from the lab of noted entrepreneur and scientific founder Tim Springer, Morphic has developed an exclusive platform to build on these discoveries, complemented by a partnership with computational chemistry leader Schrödinger, Inc., that facilitates the rapid and iterative design of clinical candidates.  Morphic was created in 2015 with support from Timothy Springer, PhD, Polaris Partners, Schrödinger Inc., and ShangPharma and raised $51.5M in 2016 from top tier investors.  In September 2018, Morphic Therapeutic completed an $80 million Series B financing round to advance multiple programs into the clinic.  Additionally, in the last 3 months, the company has forged two transformational partnerships with Abbvie and Janssen that include >$100M upfront with future milestones.  Integrins are involved in multiple disease areas, including inflammation, fibrosis, vascular diseases and cancer, and inhibitors are clinically validated.  The combination of Morphic’s deep Integrin expertise with your skills will enable a rapid path to novel and effective drugs for both orphan and blockbuster indications.  Morphic’s laboratories are located in the AstraZeneca BioHub in Waltham, MA.  We seek a highly talented and motivated scientist to join our culture of teamwork, craftsmanship, tenacity, compassion, and integrity!

Job Description:

Morphic is currently seeking a highly motivative and experienced bioinformatics scientist to work on a variety of genomics projects in the field of autoimmunity, immune-oncology, and fibrosis. This position will work on multiple internal and external datasets for target discovery and hypothesis generation.

RESPONSIBILITIES

A successful candidate will join our highly collaborative multi-functional team and use a variety of computational algorithms and tools for the discovery of new targets. Primary responsibilities will be to:

  • Develop or apply new tools, algorithms, and data mining techniques for the integrative analysis of large genomic datasets, including but not limited to single cell RNAseq and human genetics data, from both internal and external data sources
  • Extract information and knowledge from multi-dimensional genomics data-sets and annotations
  • Develop and implement innovative analysis strategies to generate meaningful hypotheses for new therapeutic targets or mechanism of actions of drug candidates
  • Prioritize targets and contribute to target validation study designs

QUALIFICATIONS

  • PhD in Bioinformatics, Biology, or equivalent, with a minimum of 3 years of working experience in computational biology and genomics in academia or industry
  • Strong scientific and technical background in biology (preferably in immunology) and NGS (preferably in single cell genomics)
  • Familiarity with biological pathways and network analyses
  • Proficiency with R, Python or other scripting language for statistical computing and graphics
  • Proven ability to analyze complexed datasets and transform information to knowledge
  • Ability to develop intuitive visualization tools for large datasets
  • Familiarity with cutting-edge bioinformatic and computational tools
  • Highly independent with demonstrated strong scientific curiosity
  • Effective communication skills with strong ability to explain computational approaches and data to non-computational scientists

Preferred but not required:

  • Experience in relational databases
  • Hands-on experience with machine learning algorithms and data mining methods
  • Experience in using NGS data to assess antibody library diversity and affinity maturation

 

Morphic Therapeutic is an equal opportunity employer committed to providing an environment that maximizes our employees’ development and achievement goals. We strive to treat each employee as an individual, as we seek to foster a spirit of teamwork to help change patients’ lives. In addition to a competitive compensation and benefits package that includes medical, dental and vision coverage, a 401K and a generous vacation and holiday schedule.

About Morphic Therapeutic

Morphic Therapeutic is a biotechnology company developing oral integrin therapies.  Drawing on integrin biology breakthroughs from the lab of noted entrepreneur and scientific founder Dr. Timothy A. Springer, Morphic has developed an exclusive platform that facilitates the rapid discovery of clinical candidates.  Morphic was created in 2015 and raised $51.5M in 2016 from top tier investors.  In 2018, Morphic Therapeutic completed an $80 million Series B financing round and formed a collaboration with Abbvie Inc. focused on the exploration of TGF-β biology in fibrotic diseases. In 2019 Morphic has formed a collaboration with Janssen Biotech, a Johnson and Johnson company to explore the potential of integrin inhibitor and activators in multiple diseases. Currently, we are advancing both partnered and fully-owned oral integrin therapeutic candidates into the clinic.  Integrin dysregulation is involved in multiple diseases that span including inflammation, fibrosis, vascular diseases, and cancer. Our immediate focus is on the areas where the clinical activity of antibody inhibitors of integrins is precedented thus enabling a rapid path to clinical proof-of-concept.

Morphic Therapeutic office is located in the AstraZeneca BioHub in Waltham, MA.  We are seeking a highly talented and motivated individual to join our culture of teamwork, craftsmanship, tenacity, compassion, and integrity.

Job description

The Director/Senior Director of Alliance and Project Management will ensure the smooth functioning of the Morphic alliances with its partners. The successful candidate will foster the team spirit in reaching collaboration objectives and will guide the team members in proactive identification and constructive resolution of collaboration challenges. She/he will manage and mentor Program Managers to high productivity in supporting collaboration objectives. The Director/Senior Director of Alliance and Project Management will additionally coordinate the advancement of the key internal development-stage program. She/he will be responsible for creating integrated program plan, for guiding the team of internal functional experts to maintain disciplined execution through anticipating and solving program challenges, and for the articulation of integrated program strategy to the company leadership.  The ideal candidate will be a self-starter, who will strive in a fast-paced, collaborative environment. She/he will report to the Chief Development Officer.

Responsibilities

  • Manage alliances to ensure that key goals and metrics for each alliance are established, tracked and met;
  • Create and execute on value-maximizing alliance management strategy for each collaboration;
  • Ensure that the governance structure is utilized to drive joint strategic and operational effectiveness;
  • Understand the partner’s people, roles, operating model, decision-making processes and stakeholders;
  • Develop a deep understanding of and serve as an internal expert on contracts guiding the alliances;
  • Understand and communicate how alliance objectives support corporate strategy and portfolio;
  • Proactively articulate alliance issues and possible resolutions to internal and partner stakeholders;
  • Guide the internal team members in the identification and resolution of collaboration challenges;
  • Lead planning for and coordinate execution of the key internal development-stage program;
  • Collaborate with the team to identify opportunities and to address challenges in a timely fashion;
  • Foster alliance and project management understanding and skills across the organization;
  • Manage and mentor Project Managers to high productivity.

Qualifications

  • Advance degree (MS, PhD, MD, PharmD, or MBA) is strongly preferred;
  • 12+ years in the pharmaceutical industry with 3+ years in program and alliance management;
  • Strong management and leadership qualities, ability to collaborate across the functional lines;
  • Extensive experience in small molecule drug development through early clinical development;
  • Demonstrated ability to develop strong relationships with key stakeholders internally and externally;
  • Excellent interpersonal, communication and negotiation skills, ability to manage difficult conversations;
  • Demonstrated skills in strategic planning, risk mitigation, problem-solving and conflict resolution;
  • Knowledge of the structure of IND, CTA and IMPD modules and submission requirements;
  • Superior coordination, organization and presentation skills, both written and oral;
  • Expert in preparation and implementation of project plans created with the input of functional experts;
  • Proven ability to work within a matrix working environment positively impacting the organization;
  • Ability to travel up to 15% of the time.

 

Morphic Therapeutic is an equal opportunity employer committed to providing an environment that maximizes our employees’ development and achievement goals. We strive to treat each employee as an individual, as we seek to foster a spirit of teamwork to help change patients’ lives. In addition to a competitive compensation and benefits package that includes medical, dental and vision coverage, a 401K and a generous vacation and holiday schedule.

About Morphic Therapeutic

Morphic Therapeutic is a biotechnology company developing a new generation of oral integrin therapies. Drawing on integrin biology breakthroughs from the lab of noted entrepreneur and scientific founder Tim Springer, Morphic has developed an exclusive platform to build on these discoveries, complemented by a partnership with computational chemistry leader Schrödinger, Inc., that facilitates the rapid and iterative design of clinical candidates. Morphic was created in 2015 with support from Timothy Springer, PhD, Polaris Partners, Schrödinger Inc., and ShangPharma and raised $51.5M in 2016 from top tier investors. In September 2018, Morphic Therapeutic completed an $80 million Series B financing round to advance multiple programs into the clinic. Last October, we announced a collaboration with AbbVie on a subset of our fibrosis programs. Under the terms of the agreement, AbbVie paid Morphic an upfront payment of $100 million for exclusive license options on product candidates directed at multiple targets. Morphic retains co-development rights in liver indications. Integrins are involved in multiple disease areas, including inflammation, fibrosis, vascular diseases and cancer, and inhibitors are clinically validated. The combination of Morphic’s deep integrin expertise with your skills will enable a rapid path to novel and effective drugs for both orphan and blockbuster indications. In addition, we recently announced that it has entered into a research and development collaboration with Janssen Biotech, Inc. (Janssen) to discover and develop novel integrin therapeutics for patients with conditions not adequately addressed by current therapies. Johnson & Johnson Innovation LLC facilitated the transaction. The collaboration focuses on several undisclosed integrin targets and will explore both inhibitors and activators of integrin function. Under the terms of the agreement, the companies will collaborate through preclinical development to identify and advance candidates. Morphic is located in the AstraZeneca BioHub in Waltham, MA. We seek a highly talented and motivated individual to join our culture of teamwork, craftsmanship, tenacity, compassion, and integrity.

Description and Responsibilities

Morphic Therapeutic is currently seeking a Research Associate I with strong in vitro and in vivo skills for fibrosis research. The candidate will work cross-functionally within the organization to contribute to the areas of immunology, fibrosis, and oncology. The candidate is expected to be multi-tasking and able to execute complex experiments with strong attention to detail under daily supervision. The candidate should be highly motivated, creative and flexible, possess strong experimental and technical research skills, have excellent communication skills, and collaborate effectively in a team environment. The responsibilities of the candidate include but are not limited to:

  • Perform standard procedures in live rodent models
  • Perform ex vivo sample analysis
  • Establish in vitro cell-based assays independently for anti-fibrotic compound evaluation
  • Design and conduct mechanism of action studies for targets of interest
  • Analyze experimental results and accurately extract information from the data for presentations to peers and management

Qualifications

Education:

B.Sc. degree with a minimum of 1-2 years of industry or academic experience in biology, pharmacology, or related field.

Required qualifications and skills:

  • In vivo skills including routine animal handling
  • Proficient with necropsy
  • Cellular biology and cell-based assay
  • Ex vivo sample processing and analysis
  • Demonstrated ability for multi-tasking and high productivity
  • Fast learner and show curiosity in new techniques

Preferred skills:

  • Familiarity with rodent models of immunology or fibrosis
  • Experience in rodent compound treatment is a plus

 

Morphic Therapeutic is an equal opportunity employer committed to providing an environment that maximizes our employees’ development and achievement goals. We strive to treat each employee as an individual, as we seek to foster a spirit of teamwork to help change patients’ lives. In addition to a competitive compensation and benefits package that includes medical, dental and vision coverage, a 401K and a generous vacation and holiday schedule.

About Morphic Therapeutic

Morphic Therapeutic is a biotechnology company developing a new generation of oral integrin therapies. Drawing on integrin biology breakthroughs from the lab of noted entrepreneur and scientific founder Tim Springer, Morphic has developed an exclusive platform to build on these discoveries, complemented by a partnership with computational chemistry leader Schrödinger, Inc., that facilitates the rapid and iterative design of clinical candidates. Morphic was created in 2015 with support from Timothy Springer, PhD, Polaris Partners, Schrödinger Inc., and ShangPharma and raised $51.5M in 2016 from top tier investors. In September 2018, Morphic Therapeutic completed an $80 million Series B financing round to advance multiple programs into the clinic. Last October, we announced a collaboration with AbbVie on a subset of our fibrosis programs. Under the terms of the agreement, AbbVie paid Morphic an upfront payment of $100 million for exclusive license options on product candidates directed at multiple targets. Morphic retains co-development rights in liver indications. Integrins are involved in multiple disease areas, including inflammation, fibrosis, vascular diseases and cancer, and inhibitors are clinically validated. The combination of Morphic’s deep integrin expertise with your skills will enable a rapid path to novel and effective drugs for both orphan and blockbuster indications. In addition, we recently announced that it has entered into a research and development collaboration with Janssen Biotech, Inc. (Janssen) to discover and develop novel integrin therapeutics for patients with conditions not adequately addressed by current therapies. Johnson & Johnson Innovation LLC facilitated the transaction. The collaboration focuses on several undisclosed integrin targets and will explore both inhibitors and activators of integrin function. Under the terms of the agreement, the companies will collaborate through preclinical development to identify and advance candidates. Morphic is located in the AstraZeneca BioHub in Waltham, MA. We seek a highly talented and motivated individual to join our culture of teamwork, craftsmanship, tenacity, compassion, and integrity.

Description and Responsibilities

Morphic Therapeutic is seeking a Research Associate with in vitro and in vivo skills for immunology, pre-clinical research in the areas of inflammation and autoimmunity. The successful candidate will join a dynamic, multi-disciplinary team of scientists, playing a key role to evaluate new immunotherapeutic strategies and drug candidates. The candidate is expected to be multi-tasking and able to execute experiments with strong attention to detail under supervision. The candidate should be highly motivated, organized, manually dexterous, and collaborate effectively in a team environment.

Responsibilities include but are not limited to:

  • Perform standard procedures in live rodent models
  • Animal study monitoring, necropsy procedures, and downstream processing of samples
  • Analyze experimental results for presentations to peers and management

Qualifications:

B.Sc. degree with 1-2 years of industry or academic experience in biology, immunology, or related field.

Required qualifications and skills:

  • In vivo skills including routine animal handling, dosing (IP and oral), and necropsy
  • Background in biology
  • Hands-on experience with molecular and cell biology methodologies
  • Demonstrated ability for multi-tasking and high productivity
  • Ability to independently follow Standard Operating Procedures (SOPs)
  • Fast learner and show curiosity in new techniques
  • Excited to be in a lab-based role
  • Skilled with MS Excel, or similar data analysis software

 

Morphic Therapeutic is an equal opportunity employer committed to providing an environment that maximizes our employees’ development and achievement goals. We strive to treat each employee as an individual, as we seek to foster a spirit of teamwork to help change patients’ lives. In addition to a competitive compensation and benefits package that includes medical, dental and vision coverage, a 401K and a generous vacation and holiday schedule.

Apply Now!